50 Biggest Movers From Yesterday



  • electroCore, Inc. ECOR shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for PTSD treatment.
  • Immuron Limited IMRN shares surged 49.6% to close at $3.83 on Wednesday. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.
  • SurgePays, Inc. SURG gained 32.1% to close at $2.80. The company recently announced 30,000 SurgePhone Wireless subscribers in December.
  • Nxt-ID, Inc. NXTD surged 30.6% to settle at $4.14.
  • Vaxxinity, Inc. VAXX gained 29.7% to close at $7.56 after the company announced the first Parkinson's disease patient has been dosed in Part B of a Phase 1 clinical trial of UB-312.
  • Fathom Digital Manufacturing Corporation FATH shares jumped 29% to close at $6.85.
  • Vinco Ventures, Inc. BBIG climbed 23.1% to close at $2.88.
  • Pintec Technology Holdings Limited PT gained 21.1% to settle at $0.6299.
  • Kidpik Corp. PIK jumped 20.7% to close at $7.30 after jumping more than 27% on Tuesday. Kidpik, last month, posted a Q3 loss of $0.22 per share.
  • Fresh Vine Wine, Inc. VINE gained 19.9% to close at $6.98 after the company reported a partnership with CRAVE American Kitchen & Sushi Bar.
  • Merida Merger Corp. I MCMJ gained 19.3% to close at $10.01. Leafly and Merida Merger Corp. I reported a $30 million convertible note financing.
  • BTCS Inc. BTCS rose 19% to settle at $6.70.
  • Immix Biopharma, Inc. IMMX jumped 18.4% to settle at $6.43 after the company announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study, surpassing the STS standard of care doxorubicin’s 0% response rate in the same mouse study.
  • Vigil Neuroscience, Inc. VIGL gained 18% to close at $14.00 amid post-IPO volatility.
  • Smart Share Global Limited EM jumped 16.7% to settle at $2.24.
  • CI&T Inc. CINT gained 16.7% to close at $13.61.
  • Ebix, Inc. EBIX climbed 15.3% to close at $35.80.
  • Vir Biotechnology, Inc. VIR gained 15.1% to settle at $40.01 following Tuesday's announcement the US government will purchase an additional 600,000 doses of sotrovimab.
  • Ucommune International Ltd UK jumped 14.8% to settle at $0.7350.
  • Mainz Biomed B.V. MYNZ gained 14.4% to close at $16.12. Mainz Biomed recently announced it acquired exclusive rights to novel mRNA biomarkers.
  • U.S. Global Investors, Inc. GROW rose 13.9% to settle at $5.81. US Global Investors recently posted Q1 EPS of $0.16.
  • OceanPal Inc. OP gained 13.3% to close at $2.21.
  • Planet Labs PBC PL shares climbed 10.5% to close at $6.23 after Goldman Sachs initiated coverage on the stock with a Buy rating and a $11 price target.
  • Qutoutiao Inc. QTT climbed 10.1% to settle at $3.06. Shares of several Chinese companies traded higher following data that showed China's inflation rose slower than expected in December, which increased policy easing optimism.
  • Jaguar Health, Inc. JAGX gained 9.7% to close at $1.02 following a 13G filing from Oasis Capital showing a 9.99% stake in the company.
  • 51job, Inc. JOBS shares gained 9.1% to settle at $50.00. 51job reported receipt of a proposal to amend merger consideration for going-private transaction.
  • inTEST Corporation INTT rose 7.9% to close at $12.89.
  • Sonendo, Inc. SONX gained 6.4% to close at $7.18. Sonendo recently issued Q4 and FY21 sales guidance above estimates.


Check out these big penny stock gainers and losers


  • Avinger, Inc. AVGR shares dipped 25.7% to settle at $0.3571 on Wednesday after the company announced a $7.6 million registered direct offering.
  • Dogness (International) Corporation DOGZ dropped 19.8% to close at
  • $2.91.
  • Nutriband Inc. NTRB shares declined 17.3% to close at $6.74.
  • Nam Tai Property Inc. NTP fell 16.9% to close at $9.58 on Wednesday. Nam Tai Property issued an update on local affairs and efforts to preserve social stability.
  • Kanzhun Limited BZ fell 15.6% to settle at $30.66.
  • Reviva Pharmaceuticals Holdings, Inc. RVPH tumbled 15.4% to settle at $2.36. The FDA recently notified Reviva Pharmaceuticals that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia.
  • Hour Loop, Inc. HOUR fell 14.9% to close at $5.73. The company recently priced its IPO at $4 per share.
  • TDH Holdings, Inc. PETZ dipped 14.8% to settle at $0.5859 on above-average volume despite not seeing any seeing any company-specific news.
  • Theravance Biopharma, Inc. TBPH shares fell 14.8% to close at $9.51. Theravance Biopharma recently reported enrollment of first patient in YUPELRI® Phase 4 study.
  • Koninklijke Philips N.V. PHG shares dipped 14.7% to settle at $33.09 on Wednesday after the company hiked the cost of its recall of ventilators and warned earnings would take a big hit from global supply chain shortages.
  • Bone Biologics Corporation BBLG tumbled 14% to close at $3.7050.
  • Kronos Bio, Inc. KRON fell 13.8% to close at $11.04.
  • Aclaris Therapeutics, Inc. ACRS fell 13.6% to close at $11.11. Providing a R&D update, Aclaris Therapeutics said David Gordon, its chief medical officer left the company, effective Jan. 7. The company also announced update on its two Phase 2 programs that evaluate zunsemetinib in subjects with moderate to severe rheumatoid arthritis and in subjects with moderate to severe hidradenitis suppurative.
  • Pop Culture Group Co., Ltd CPOP dipped 13.5% to settle at $2.05.
  • ATA Creativity Global AACG fell 12.2% to close at $2.01.
  • Prothena Corporation plc PRTA shares dropped 11% to close at $37.47 on Wednesday.
  • Nisun International Enterprise Development Group Co., Ltd NISN fell 10.7% to settle at $2.26. Nisun recently reported a cooperative supply chain agreement with Henan Shiwugu.
  • Phio Pharmaceuticals Corp. PHIO shares declined 10% to close at $0.9271. Phio Pharmaceuticals shares gained 8% on Tuesday after the company announced regulatory clearance of the clinical trial of PH-762 to treat melanoma.
  • Jefferies Financial Group Inc. JEF fell 9.3% to close at $37.59 after the company reported worse-than-expected Q4 sales results.
  • Wipro Limited WIT fell 8.5% to close at $8.70 following Q3 results. The company reported third-quarter FY22 gross revenue of $2.7 billion, an increase of 3.3% Q/Q and 29.6% Y/Y.
  • Lucira Health, Inc. LHDX shares fell 7.3% to close at $7.46. The company recently said that its Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test is now available in the Optum Store.
  • Biogen Inc. BIIB fell 6.7% to settle at $225.34 following a U.S. Centers For Medicare listing for "Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease."
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers